Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs... Show more
The Moving Average Convergence Divergence (MACD) for OPHLY turned positive on May 27, 2025. Looking at past instances where OPHLY's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where OPHLY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OPHLY advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on June 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on OPHLY as a result. In of 107 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The 10-day moving average for OPHLY crossed bearishly below the 50-day moving average on May 09, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OPHLY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
OPHLY broke above its upper Bollinger Band on June 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for OPHLY entered a downward trend on May 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.732) is normal, around the industry mean (5.632). P/E Ratio (11.403) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.004). Dividend Yield (0.027) settles around the average of (0.161) among similar stocks. P/S Ratio (2.874) is also within normal values, averaging (3.643).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. OPHLY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPHLY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
Industry PharmaceuticalsMajor
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
APDWX | 10.53 | -0.13 | -1.22% |
Artisan Value Income Advisor | |||
NWHZX | 75.73 | -1.19 | -1.55% |
Nationwide Geneva Small Cap Gr A | |||
TISCX | 27.41 | -0.45 | -1.62% |
Nuveen Large Cap Responsible Eq R6 | |||
WGICX | 7.45 | -0.16 | -2.10% |
Wasatch Micro Cap Institutional | |||
NWGSX | 27.66 | -0.60 | -2.12% |
Nationwide WCM Focused Sm Cp Instl Svc |
A.I.dvisor indicates that over the last year, OPHLY has been loosely correlated with OTSKY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if OPHLY jumps, then OTSKY could also see price increases.
Ticker / NAME | Correlation To OPHLY | 1D Price Change % | ||
---|---|---|---|---|
OPHLY | 100% | -1.65% | ||
OTSKY - OPHLY | 42% Loosely correlated | -1.29% | ||
ALPMY - OPHLY | 33% Loosely correlated | -1.63% | ||
BAYRY - OPHLY | 23% Poorly correlated | -1.99% | ||
CHGCY - OPHLY | 22% Poorly correlated | -1.45% | ||
CSPCY - OPHLY | 20% Poorly correlated | -0.77% | ||
More |